GLUTATHIONE S-TRANSFERASE-MU IN HUMAN LYMPHOCYTE AND LIVER - ROLE IN MODULATING FORMATION OF CARCINOGEN-DERIVED DNA ADDUCTS

被引:73
作者
LIU, YH
TAYLOR, J
LINKO, P
LUCIER, GW
THOMPSON, CL
机构
[1] NIEHS,BIOCHEM RISK ANAL LAB,RES TRIANGLE PK,NC 27709
[2] NIEHS,EPIDEMIOL BRANCH,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1093/carcin/12.12.2269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glutathione transferase (GT) activity towards trans-stilbene oxide (tSBO), benzo[a]pyrene-4,5-oxide (B[a]PO) and 1-chloro-2,4-dinitrobenzene (CDNB) was measured in human liver and lymphocytes. GT-tSBO activity is catalyzed by GT-mu which has polymorphic expression in human lymphocytes. Our results show that activity of GT-tSBO in lymphocytes correlates with its activity in liver (r = 0.7, P < 0.001). GT activity towards BPO (GT-BPO) also correlated with GT-tSBO in lymphocytes and liver. However, interindividual variation of GT-BPO is less than that of GT-tSBO, suggesting that BPO may not be as specific a substrate for GT-mu and therefore other GT isozymes may contribute to BPO conjugation. Conjugation of CDNB by GT was not different using cytosols from either high or low GT-mu individuals. The functional significance of the GT-mu polymorphism was evaluated by measuring its effect on benzo[a]pyrene (B[a]P)- and aflatoxin B1 (AFB1)-DNA adduct formation in vitro. Human liver cytosols prepared from persons having low or high GT-tSBO activity were incubated with human liver microsomes, calf thymus DNA and B[a]P or AFB1. HPLC analysis revealed that the major B[a]P adduct was dG(N2)-7-beta, 8-alpha-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE-dG). BPDE-dG adducts were decreased equally by cytosols from either low or high conjugators. In contrast, AFB1-DNA binding was inhibited to a greater extent in high conjugators than low conjugators. HPLC analysis demonstrates that adducts formed were AFB1-FAPyr and AFB1-N7-Gua. The correlation between AFB1-DNA adduct concentrations and GT-mu activity was highly significant with a correlation coefficient of r = 0.88 at P < 0.001. These results suggest that GT-mu plays an important role in detoxifying DNA reactive metabolites of AFB1 and this enzyme may be a susceptibility marker for AFB1 related liver cancer. Moreover, our data demonstrate that lymphocytes are a reliable surrogate tissue for detecting liver GT-mu polymorphisms.
引用
收藏
页码:2269 / 2275
页数:7
相关论文
共 47 条
[1]  
BELL DA, 1991, 1991 ANN M ENV MUT S
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
Busby WF, 1984, ACS MONOGR SER, V182, P945
[4]  
Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9
[5]   GST1 GENE DELETION DETERMINED BY POLYMERASE CHAIN-REACTION [J].
COMSTOCK, KE ;
SANDERSON, BJS ;
CLAFLIN, G ;
HENNER, WD .
NUCLEIC ACIDS RESEARCH, 1990, 18 (12) :3670-3670
[6]  
COOPER CS, 1983, PROG DRUG METAB, V7, P295
[7]   STABLE EXPRESSION OF HUMAN CYTOCHROME-P450IA2 CDNA IN A HUMAN LYMPHOBLASTOID CELL-LINE - ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF AFLATOXIN-B1 [J].
CRESPI, CL ;
STEIMEL, DT ;
AOYAMA, T ;
GELBOIN, HV ;
GONZALEZ, FJ .
MOLECULAR CARCINOGENESIS, 1990, 3 (01) :5-8
[8]  
DEGEN GH, 1981, CARCINOGENESIS, V5, P841
[9]   METABOLIC-ACTIVATION OF AFLATOXIN-B1 - PATTERNS OF DNA ADDUCT FORMATION, REMOVAL, AND EXCRETION IN RELATION TO CARCINOGENESIS [J].
ESSIGMANN, JM ;
CROY, RG ;
BENNETT, RA ;
WOGAN, GN .
DRUG METABOLISM REVIEWS, 1982, 13 (04) :581-602
[10]  
GARNER RC, 1973, CHEM-BIOL INTERACT, V6, P125, DOI 10.1016/0009-2797(73)90079-3